Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT02137044

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Collaborative Care (CC)

What it measured

Main measures

  • Change in Control of Pain

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Pain
  • Change in Control Of Depression

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Thinking and memoryMood and sleep

Other measures (6)

  • Change in Depression Severity

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Mood and sleep
  • Change in Quality of Depression Care

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Mood and sleep
  • Change in Pain Severity

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Pain
  • Change in Disability

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

  • Change in Health-Related Quality of Life

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Walking and mobilityPainMood and sleepQuality of life (reported by participants)
  • Improvement and Satisfaction with Care

    Within 2 weeks following study enrollment, about 4 Months following study enrollment, about 10 months following study enrollment

    Quality of life (reported by participants)

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Patient has a definitive diagnosis of MS confirmed by subjects' MS physician in the University of Washington (UW) MS Center; * Patient has received care and plans to continue to receive care at the UW MS Center during enrollment period; * Patient has access to and is able to communicate over the telephone (we will provide phone headsets if needed) to allow participation in the telehealth components of the study; * Patient can read, speak and understand English; * Patient is at least 18 years of age. * Patient reports a clinically significant problem with pain and/or depression.

Exclusion criteria

* Patient represents a high suicide risk; * Patient reports symptoms of a current psychotic disorder or diagnosis of bipolar disorder with current psychotic features at time of screening; * Subject attends appointments more than once per month with a psychiatrist for treatment of depression; * Patient reports planning major surgery in the next ten months; * Patient reports alcohol or psycho-active substance dependence within past month; * Patient has moderate to severe cognitive impairment.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this study is to: (1) test the benefits of the patient-centered collaborative care treatment approach for persons with MS who also have depression and/or pain; and also (2) test whether this approach improves quality of life, patient satisfaction, adherence to other treatments, and quality of care in the MS care system.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jul 2014

    2. Main results due

      Apr 2017

    3. Finished

      Apr 2017

    Assembled by software from public sources.